Patient Survival & Hospitalization
The Fresenius Health Partners Program Achieved Improvement in Patient Mortality and Hospitalization Outcomes for the 2006 to 2008 Evaluation Period:
- One Year Mortality (36% reduction)
- Two Year Mortality (24% reduction)
- "All Cause" First Hospitalizations (reduced by 13% for One Year) and (reduced by 20% for Two Year)
- "Cardiovascular Disease" First Hospitalizations (reduced by 14% for One Year) and (reduced by 21% for Two Year)
|  |
Reducing Costs
The Fresenius Health Partners Program Achieved Improvement (reductions) in Costs and Utilization of Services in the Third year of the Demonstration Project (2008) in the Following Measures (range of improvement varied by analysis method):
- Hospital Admissions (8% to 12%)
- Hospital Readmissions (11% to 19%)
- Physician Visits (19% to 27%)
- SNF Stays (43% to 49%)
- ER Visits (3% to 4%)
- Cost of Care (5% to 6%)
|  |
*The ESRD DM Demonstration Project was a five year demonstration project (2006 to 2010) conducted by the Centers for Medicare and Medicaid Services (CMS) to test the impact of expanded integrated care (disease management) approaches applied to the Medicare ESRD patient population. The first three years of the Demonstration (2006 through 2008) were evaluated under this project. The analyses were independently performed by Arbor Research Collaborative for Health (the CMS Evaluation Contractor) and results were presented by Arbor Research at the American Society of Nephrology Annual Meeting in November 2010.
The Arbor Research Collaborative for Health abstracts regarding the CMS ESRD Demonstration Project can be viewed in the links below. The Fresenius Health Partners program is identified as DMO C.
